Pulmonary hypertension trials recruiting in North Carolina

All Pulmonary hypertension trials nationally

Cities in North Carolina

Recruiting trials in North Carolina

• 129 Xenon Imaging in Patients Treated With Sotatercept
  NCT06351345 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · North Carolina: Durham
• A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
  NCT07333183 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · North Carolina: Greensboro
• An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
  NCT06129240 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · North Carolina: Chapel Hill
• DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT06388421 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Chapel Hill, Durham, Greensboro, Greenville
• Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
  NCT06911632 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Winston-Salem
• Pulmonary Hypertension Association Registry
  NCT04071327 · Phase: Not specified · Ages: 0 Years and older · Sex: All (male and female) · North Carolina: Chapel Hill, Durham
• Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
  NCT06526195 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Chapel Hill, Charlotte
• Xenon MRI Pulm Hypertension
  NCT04991454 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · North Carolina: Durham